Douglas Lane & Associates, LLC Halozyme Therapeutics, Inc. Transaction History

Douglas Lane & Associates, LLC

  • $7.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 19, 2020
SELL
$25.74 - $29.63 $193,050 - $222,225
-7,500 Closed
0 $0
Q2 2020

Jul 28, 2020
SELL
$16.25 - $26.81 $40,625 - $67,025
-2,500 Reduced 25.0%
7,500 $201,000
Q1 2020

Apr 20, 2020
BUY
$13.9 - $21.83 $139,000 - $218,299
10,000 New
10,000 $180,000

Others Institutions Holding HALO

# of Institutions
542
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.36B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email